Last reviewed · How we verify
a swab according to the method of Levine
a swab according to the method of Levine is a Biologic drug developed by Fondation Hôpital Saint-Joseph. It is currently in Phase 1 development.
At a glance
| Generic name | a swab according to the method of Levine |
|---|---|
| Sponsor | Fondation Hôpital Saint-Joseph |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- a swab according to the method of Levine CI brief — competitive landscape report
- a swab according to the method of Levine updates RSS · CI watch RSS
- Fondation Hôpital Saint-Joseph portfolio CI
Frequently asked questions about a swab according to the method of Levine
What is a swab according to the method of Levine?
a swab according to the method of Levine is a Biologic drug developed by Fondation Hôpital Saint-Joseph.
Who makes a swab according to the method of Levine?
a swab according to the method of Levine is developed by Fondation Hôpital Saint-Joseph (see full Fondation Hôpital Saint-Joseph pipeline at /company/fondation-h-pital-saint-joseph).
What development phase is a swab according to the method of Levine in?
a swab according to the method of Levine is in Phase 1.